Psilocybin: clinical potential, mechanistic insights, and biotechnological advances for scalable production.

Psilocybin, a tryptamine-derived alkaloid from Psilocybe mushrooms, has emerged as a high-value biopharmaceutical candidate due to its promising applications in mental health. While clinical studies highlight its rapid and sustained antidepressant ef…

Preview only. Read the full abstract at the source